Improving Mental Health Care: A Case Study
|
|
- Robyn Shields
- 5 years ago
- Views:
Transcription
1 Improving Mental Health Care: A Case Study
2 Why Improve Mental Health Care? Because the prevalence and costs of mental health problems are increasing in America despite the high prescribing of psychotropic drugs. Depression is the number one risk factor impacting medical spend per multiple studies latest study reported a 48% increase for depression. Mental Health America reported: Depression now affects more than 21 million American children and adults annually Depression is the leading cause of disability in the United States for individuals ages 15 to 44 2
3 Depression Has an Impact on Mean Health Scores More Than Other Chronic Conditions Depression had the largest effect on worsening mean health scores Mean Health Score (0-100) *P<.0001 * * * Depression Only * * 73 P< N=245,404 * Depressed respondents had lowest mean score among all chronic conditions (P<.0001) Depressed respondents with another chronic condition had lower mean health scores than respondents with the chronic condition alone (P<.01) 4 59 One Chronic Condition Depression + One Chronic Condition 90.6 = No Chronic Condition Conditions 1. Asthma 2. Angina 3. Arthritis 4. Diabetes Moussavi S, et al. Lancet. 2007;370:
4 U.S. Disability Claims for Mental Health Millions of adults, 18 to 66 years old Source: U.S. Social Security Administration Reports,
5 Top 5 Therapeutic Classes by Prescription DISPENSED PRESCRIPTIONS (Millions) TOTAL US MARKET 4,024 3,993 3,949 3,866 3,825 1 Antidepressants Lipid Regulators Narcotic Analgesics Antidiabetes Ace Inhibitors Source: IMS Health, National Prescription Audit, Dec 2011 Updated February 23, 2012 The annual dollar spend for antidepressants in 2011 was over $11B 5
6 The Paradox of Antidepressants and other Psychotropic Drugs These drugs have been documented to help individuals dealing with mental health conditions These drugs have been documented to harm individuals dealing with mental health conditions Which statement is valid? 6
7 Effects of the Drugs Steven Hyman, M.D., as Director for the National Institute of Mental Health (NIMH), wrote a summary of the research on psychotropic drugs in which he stated, (Psychotropic drugs) create perturbations in neurotransmitter functions The chronic administration of the drug then causes substantial and long lasting alterations in neural function After a few weeks, he concluded, the person s brain is functioning in a manner that is qualitatively as well as quantitatively different from the normal state So instead of correcting a chemical imbalance (as claimed), the drugs create a chemical imbalance. 7
8 What do the Studies Report? Of 74 (short term) studies on depression registered with the FDA, 38 reported a positive outcome and 36 reported a negative outcome Longer term studies report up to 80% of patients maintained on an antidepressant suffer a recurrence of symptoms, and once that initial treatment response is lost, continued efforts to treat the patient with antidepressants frequently result in poor response and the rise of treatment resistant depression * *Source: Rif El Mallakh, M.D., Director, Mood Disorders Clinical and Research Program, University of Louisville School of Medicine. 8
9 The STAR*D Trial Confirms: Depression Runs a Chronic Course Today Findings from the National Institute of Mental Health s STAR*D study, which was the largest study of depression ever conducted: 40% 20% 0% 38% Remitted During Study 3% Remained in Remission 38% of the patients properly enrolled in the trial remitted during one of the four stages of drug treatment. Only 3% of the patients remitted and then stayed well throughout the 12 month follow up (108 of 4,041.) The remaining patients either failed to remit, relapsed during the follow up, or dropped out. Source: Pigott, E. Efficacy and effectiveness of antidepressants. Psychother Psychosom 79 (2010):
10 What is the Answer? It depends on how psychotropic drugs are being prescribed When used appropriately and judiciously, these medications can enhance the quality of life for some, particularly short term There is convincing (and growing) evidence that these drugs worsen the long term course of depression for a number of individuals The treatment and risks of psychotropic drugs need to be managed are they? 10
11 It Starts with Who s Writing the Scripts 100% 75% 50% 25% 0% Prescriptions by Non Psychiatrist 79% 87% Antidepressants Anxiolytics 79% of prescriptions for antidepressants were written by non psychiatrists 87% of prescriptions for anxiolytics were written by non psychiatrists Open Minds, September 24, 2009, reporting on a study in which researchers reviewed 472,173 prescriptions filled between August 2006 and July 2007 from the IMS National Prescription Audit Plus database. Does this produce a positive course of care? 11
12 What the Research is Reporting A significant proportion of individuals with behavioral health problems are treated exclusively in the general medical setting, which has become the de facto mental healthcare system significant quality problems have been found with general medical providers screening, treatment, and monitoring practices. An Employer s Guide To Behavioral Health Services, released by the National Business Group on Health, December More Americans are being prescribed multiple psychiatric medications for use at the same time, but most people diagnosed with recent depression don t get adequate treatment, according to two independent studies published Monday. Studies: Mental Ills Are Often Overtreated Or Undertreated, Wall Street Journal, January 5,
13 Supporting Study Only 12.7% of individuals seeking mental health treatment in the general medical setting received minimally adequate care compared to 43.9% of patients treated in the specialty mental health sector. 50% 25% 0% Minimally Adequate Care 12.7% General Medical Setting 43.9% Specialty Mental Health Sector Percent of patients receiving minimally adequate care in the primary care setting Percent of patients receiving minimally adequate care in the specialty mental health sector National Co morbidity Survey Replication. Archives of General Psychiatry (Also reported in the Interim Final Rules for the Federal Mental Health Parity Act) 13
14 The Next Wave With many of the top selling antidepressants coming off patent, stronger and more costly antipsychotic drugs are now being marketed as a magic bullet for depression through physician education and direct consumer advertising, i.e. Abilify and Seroquel, which have potentially serious side effects. Increased Blood Sugar Antipsychotic Side Effects Weight Gain Elevated Lipids & Cholesterol Potentially Irreversible Movement Disorder 14
15 The Drug Pipeline Very aggressive physician education drives the high prescribing of drugs in the general medical setting, including psychotropic drugs. Just how aggressive are some pharmaceutical manufacturers? 15
16 PIP Solution Target Population(s): Health plan benefit sponsors with more than 10 percent of their members having filled a PIP covered prescription in a recent 12 month period. An analysis of summary drug data across a number of health plans documented that between 80 and 90 percent of the plans met said criteria. Objectives for Solution: For mental health treatment occurring in the primary care setting: Identify and address gaps in clinical care Coordinate solution focused treatments Improve outcomes Increase number of patients who can successfully be tapered from medications (under prescribing physician s care) after achieving target symptom reduction 16
17 PIP Solution Implementation Plan and Metrics: Establish a secure two way data feed with the PBM Filter on drug data to identify potential candidates Coordinate a targeted member outreach Manage a concurrent authorization process with the PBM Provide telephonic evaluations, screenings and coaching Provide clinical outcomes to prescribing physician Coordinate with EAP for free psychotherapy and other resources Monitor side effects and drug adherence Provide education and feedback to participants and physicians 17
18 PIP Solution Results: A case study with St. Joseph s Hospital and Medical Center in Phoenix, AZ documented: Hundreds 200% 160% 120% 80% 40% 0% 96% 200% 96 percent higher medication compliance for PIP participants at 1 year 200 percent average increase in EAP engagement over 4 years 30% 60% 30 percent reduction in the PIP target drug spend within 15 months 60 percent of the PIP participants scored reduced symptoms based on multiple standardized screenings 29.4% 29.4 percent overall average reduction in total medical claims costs for the PIP participants in the year after enrolling in the PIP compared to prior year 18
19 PIP Solution Pricing: The PIP is priced on a per employee per month (pepm) basis that is determined for each group from an analysis of their summary drug data. Using a Concurrent Authorization (CA) process to maximize engagement, the PIP is provided with a financial guarantee reduced drug spend for the PIP target drugs (on a pepm basis) will exceed the cost of the PIP within 12 months or the difference will be refunded. It is important to note that the PIP is compliant with HIPAA, the ADA, and the mental health parity regulations, per established legal opinions. 19
20 Consider Why are so many Americans today, while they may not be disabled by mental illness, nevertheless plagued by chronic mental problems by recurrent depression, by bipolar symptoms, and by crippling anxiety? If we have treatments that effectively address these disorders, why has mental illness become an ever greater health problem in the United States? Anatomy of an Epidemic Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America, Robert Whitaker, (2010) pg. 5 Think about the millions of Americans being prescribed psychotropic drugs by primary care physicians without any psychiatric diagnosis, monitoring, psychotherapy, or follow up to evaluate their conditions and changes in symptoms down the road. 20
21 Conclusion When one considers all of the available data associated with the prescribing of psychotropic drugs, the conclusion becomes clear. A grim picture is painted for the health and productivity of many Americans if interventions are not coordinated to improve treatments and health outcomes, leading to a reduction in the long term use of psychotropic drugs. The PIP Solution is a means to the improvement needed. The Problem is Clear The Solution is Proven The Cost is Free 21
22 For additional information, please contact us: Corporate Headquarters Richmond Ave. Suite 1100 Houston, Texas Phone: (713) Toll Free: (866)
Printing: Psychiatric Drugging of Infants and Toddlers in the US - Part I
OpEdNews Page 1 of 5 Original Content at http://www.opednews.com/articles/psychiatric-drugging-of-in-by-evelyn-pringle-100419-821.html April 19, 2010 Psychiatric Drugging of Infants and Toddlers in the
More informationBrain Resource. For personal use only. riding the wave of demand for brain health solutions
Brain Resource riding the wave of demand for brain health solutions Dan Segal, COO dans@brainresource.com Sydney and San Francisco May 2011 1 10 year track record Founded 2001, international research consortium
More informationTreatment for Bipolar Disorder
A Resource for Consumers Treatment for Living with bipolar disorder can be a challenge. With the help of your treatment team, family, friends, and by sticking to a treatment plan, you may be able to better
More informationAdherence in A Schizophrenia:
Understanding and Diagnosing Bipolar Disorder Treatment Promoting for Bipolar Treatment Disorder Adherence in A Schizophrenia: Resource for Providers Engagement Strategies for Health Care Providers, Case
More informationCurbing the High Rates of Psychotropic Medication Prescriptions among Children and Youth in Foster Care
Curbing the High Rates of Psychotropic Medication Prescriptions among Children and Youth in Foster Care Appendices Appendix A Psych Meds Data Indicators by State The data elements being collected by the
More informationUnmanaged Behavioral Health Puts Your Company At Risk. Presented by: Dr. Sam Mayhugh Integrated Behavioral Health
Unmanaged Behavioral Health Puts Your Company At Risk Presented by: Dr. Sam Mayhugh Integrated Behavioral Health Behavioral Health Management Webinar Overview History of BH management Prevalence of behavioral
More informationTackling Depression: The State of Tennessee s Be Well At Work Program Approach
Tackling Depression: The State of Tennessee s Be Well At Work Program Approach Director of the Program on Health, Work and Productivity, Tufts Medical Center John Allen, LCSW, CEAP, SPHR Director of Behavioral
More informationpaint a realistic picture of your organization s health
plan analytics paint a realistic picture of your organization s health Impressionism has no place in your health care benefit plan. Arm yourself with the facts. Uses up-to-date client-specific data Clears
More informationIntroducing DIA-TEC CLOUDTM. Technology. Education. Community. Your NEW Strategy for Diabetes Cost Management from the Experts at DECM
Introducing DIA-TEC CLOUDTM Technology. Education. Community. Your NEW Strategy for Diabetes Cost Management from the Experts at DECM Technology. Education. Community. Diabetes happens in real time. Now,
More informationGenomind and The Genecept Assay
Genomind and The Genecept Assay A Growing Problem of Psychiatric Conditions One in four adults, approximately 61.5 M American adults suffer from mental illness 1 ; depression will become the largest health
More informationUnderstanding the Value of Generic Drugs
Understanding the Value of Generic Drugs Generic drugs can help you get the most out of your health care budget. 05.02.306.1 (8/05) Many people believe that when something costs more, it must be of higher
More informationChild and Adolescent Psychiatry Trends. ADAMHS Board - 28 Oct 2014
Child and Adolescent Psychiatry Trends ADAMHS Board - 28 Oct 2014 Current Need for Child and Adolescent Psychiatrists There are currently approximately 7400 Child and Adolescent Psychiatrists in Practice
More informationUtah. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Utah Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view
More informationReshaping the Enrollment Strategy: Creating a Health Management Program That Sustains Employee Engagement
Reshaping the Enrollment Strategy: Creating a Health Management Program That Sustains Employee Engagement What s my why? Making your tomorrow a healthier today Americas weight problem 69% of U.S. adults
More informationThe Value of Providing Collaborative Care Models For Treating Employees with Depression
The Value of Providing Collaborative Care Models For Treating Employees with Depression Summary Depression is one of the costliest health issues for employers because of its high prevalence and co-morbidity
More informationADMINISTRATIVE POLICY AND PROCEDURE
Page 1 of 6 SECTION: Medical SUBJECT: Electroconvulsive Therapy (ECT) DATE OF ORIGIN: 10/1/96 REVIEW DATES: 7/1/98, 10/1/99, 7/1/02, 7/1/04, 10/1/05, 5/1/09, 1/3/13, 7/1/15, 8/1/16 EFFECTIVE DATE: 3/24/17
More informationIntroducing ValueOptions Clinical Care Alerts
Introducing ValueOptions Clinical Care Alerts January 2013 Agenda What are Clinical Care Alerts? How does it work? What are the benefits? Questions and Answers 2 The Issue of Poor Medication Adherence
More informationThe Opioid Epidemic and How It is Impacting the Workplace. July 24, 2018
The Opioid Epidemic and How It is Impacting the Workplace July 24, 2018 In 2016 CDC reports a 300% increase in opioid prescription sales since 1999 without an overall change in reported pain National Safety
More informationThe Impact of Opioid Use and Abuse on Medical Community, Businesses, Social Organizations and Individiuals and Their Families
The Impact of Opioid Use and Abuse on Medical Community, Businesses, Social Organizations and Individiuals and Their Families THE MAGNITUDE OF THE OPIOID EPIDEMIC THE COSTS TO LOCAL, STATE AND NATIONAL
More informationThe Evidence Is In. Our Drug-Based Paradigm of Care Has Failed--Finding Ways to Humanistic Approaches. Robert Whitaker/Jaakko Seikkula August 2014
The Evidence Is In Our Drug-Based Paradigm of Care Has Failed--Finding Ways to Humanistic Approaches Robert Whitaker/Jaakko Seikkula August 2014 U.S. Disability in the Prozac Era Millions of adults, 18
More informationPUTTING OUT THE ADDICTION:
PUTTING OUT THE ADDICTION: Tobacco Cessation and Prevention Programs INDUSTRY PULSE FROM THE HEALTHCARE INTELLIGENCE NETWORK TM White paper analysis of HIN monthly e-survey results on trends shaping the
More informationFL Medicaid Drug Therapy Management Program for Behavioral Health Monitoring for Safety and Quality
FL Medicaid Drug Therapy Management Program for Behavioral Health Monitoring for Safety and Quality April 23, 2014 Pensacola, FL Presentation Objectives To briefly describe the program and how its components
More informationPosition Profile Chief Executive Officer Feeding America San Diego San Diego, CA
Position Profile Chief Executive Officer Feeding America San Diego San Diego, CA Feeding America San Diego is seeking an experienced and inspirational Chief Executive Officer to lead this impactful and
More informationMedi Cal Managed Care. Melissa Lamer, PharmD, BCPP July 31 st, 2014
Pharmacy Benefit Carve Outs in Medi Cal Managed Care Melissa Lamer, PharmD, BCPP July 31 st, 2014 2 The Behavioral Health Carve Out Services Carved Out to the County Starting 1/1/2014 Medi Cal plans now
More informationCyber Liability and Crime Update
Cyber Liability and Crime Update Cyber Liability Probability of a Data Breach 2 3 Cyber Liability Challenges Carriers are not as forthcoming with sharing data as we would like to see Large uptick in ransomware
More informationThe Value of Walgreens
The Value of Walgreens How Walgreens improves employer health plans through access, quality and lower costs Why millions of patients choose Walgreens And your options to move forward with Walgreens Walgreens
More informationWomen In Transition Resident Application
The mission of Women in Transitions is to provide a drug and alcohol free community that allows w The mission of Women in Transitions is to provide a drug and alcohol free community that allows women to
More informationA COMPREHENSIVE APPROACH TO MANAGING DIABETES
A COMPREHENSIVE APPROACH TO MANAGING DIABETES Programs and services to help individuals avoid costly complications and improve outcomes 2 0 1 8 ENTER Supporting each member with targeted guidance and services.
More informationDepression Screening: An Effective Tool to Reduce Disability and Loss of Productivity
Depression Screening: An Effective Tool to Reduce Disability and Loss of Productivity Kay n Campbell. EdD. RN-C. COHN-S, FAAOHN ICOH Cancun, Mexico March, 2012 What Is It? Common mental disorder Affects
More informationThe South African Depression and Anxiety Group (SADAG) Competition Commission: Market Inquiry into the Private Healthcare Sector
The South African Depression and Anxiety Group (SADAG) Competition Commission: Market Inquiry into the Private Healthcare Sector Introduction SADAG is registered NGO since 1994 Leading Mental Health Advocacy
More informationDrug Use Evaluation: Low Dose Quetiapine
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationGuideline scope Persistent pain: assessment and management
National Institute for Health and Clinical Excellence [document type for example, IFP, QRG] on [topic] Document cover sheet Date Version number Editor 30/08/2017 1 NGC Action 1 2 3 4 5 6 7 8 9 10 11 12
More informationHear better, Live fully.
EPIC Hearing Healthcare 3191 W. Temple Ave Suite 200 Pomona, CA 91768 Corporate Toll Free: 877.606.3742 Email: sales@epichearing.com www.epichearing.com Hear better, Live fully. ASO-2013 ASO Savings Plan
More informationQuality ID #411 (NQF 0711): Depression Remission at Six Months National Quality Strategy Domain: Effective Clinical Care
Quality ID #411 (NQF 0711): Depression Remission at Six Months National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Outcome DESCRIPTION:
More informationPsychotropic Medication. Including Role of Gradual Dose Reductions
Psychotropic Medication Including Role of Gradual Dose Reductions What are they? The phrase psychotropic drugs is a technical term for psychiatric medicines that alter chemical levels in the brain which
More informationINFORMED CONSENT FOR PSYCHOTROPIC MEDICATION
INFORMED CONSENT FOR PSYCHOTROPIC MEDICATION Richard LaVallo Attorney at Law Disability Rights Texas October 25, 2013 Why Does Informed Consent Matter? Under the common law, a physician has a duty to make
More informationSubmitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis
STATEMENT FOR THE RECORD Submitted to the House Energy and Commerce Committee Federal Efforts to Combat the Opioid Crisis October 25, 2017 America s Health Insurance Plans 601 Pennsylvania Avenue, NW Suite
More information2017 Drug Trends Series
2017 Drug Trends Series Part 1 Evaluating the traditional view Retail and mail-order prescriptions Published April 2018 1 2017 Drug Trends Series Traditional View First Script A year of important progress
More informationSpinal Technology Upgrades its Security Posture
Featured Case Study Spinal Technology Upgrades its Security Posture TEXAS SPINE-IMAGING LEADER PROTECTS PATIENT DATA IN THE CLOUD Featured Case Study Spinal Technology Upgrades its Security Posture TEXAS
More informationJukti Kumar Kalita, PhD Business Analytics and Insights Pfizer Presented at:
Hospital to Retail Spillover Analysis and Its Impact on Commercial Decision Making Jukti Kumar Kalita, PhD Business Analytics and Insights Pfizer Presented at: 1 Disclaimer The information provided and
More informationSupernus Pharmaceuticals
Supernus Pharmaceuticals Jefferies 2016 Healthcare Conference May 2016 1 Safe Harbor Statement This presentation and other matters discussed today or answers that may be given to questions asked include
More informationCanadian Mental Health Association
Canadian Mental Health Association Manitoba and Winnipeg Supports & Services Founded in 1918, CMHA National is a Canada-wide charitable organization with 87 branches in over 330 communities across the
More informationREFERENCE CODE GDHC366DFR PUBLICAT ION DATE FEBRUARY 2014 CARIPRAZINE (SCHIZOPHRENIA) FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC366DFR PUBLICAT ION DATE FEBRUARY 2014 CARIPRAZINE (SCHIZOPHRENIA) Executive Summary Table below provides a summary of the key metrics for Cariprazine in the seven major pharmaceutical
More informationMEDICINES PROMOTION AND RATIONAL USE : The Spanish Experience JOSE LUIS DOPICO
MEDICINES PROMOTION AND RATIONAL USE : The Spanish Experience JOSE LUIS DOPICO LEGAL FRAMEWORK General Health Act (1986): Established a National Health System in Spain in accordance with the following
More informationYour Partnership in Health Report: Chronic Conditions ABC Company and Kaiser Permanente
Your Partnership in Health Report: s ABC Company and Kaiser Permanente Measurement Period: JUL-01-2012 through JUN-30-2013 Report Date: DEC-31-2013 Commercial All Members Partnership in Health (PIH) reports:
More informationSupernus Pharmaceuticals
Supernus Pharmaceuticals Investor Presentation March 2017 1 Safe Harbor Statement This presentation and other matters discussed today or answers that may be given to questions asked include forward-looking
More informationAPNA 26th Annual Conference Session 1012: November 7, 2012
Fighting Stigma Through Social Inclusion and a Whole Person Approach to Wellness American Psychiatric Nurses Association 26 th Annual Conference Pittsburgh, PA November 9, 2012 Wilma Townsend, M.S.W. Acting
More informationMedication trends shaping workers compensation. A 2018 update of the prevailing industry influences impacting pharmacy outcomes
Medication trends shaping workers compensation A 2018 update of the prevailing industry influences impacting pharmacy outcomes This page intentionally left blank Trends impacting workers compensation pharmacy
More informationThe dramatic growth of managed. Use of Psychiatrists, Psychologists, and Master s-level Therapists in Managed Behavioral Health Care Carve-Out Plans
Use of Psychiatrists, Psychologists, and Master s-level Therapists in Managed Behavioral Health Care Carve-Out Plans Roland Sturm, Ph.D. Ruth Klap, Ph.D. Objective: Outpatient claims data from a managed
More informationPediatric Behavioral Health Medication Initiative Prior Authorization (PA) Request Form
Pediatric Behavioral Health Medication Initiative Prior Authorization (PA) Request Form Please fax form to 617.673.0988 or mail to Tufts Health Plan, 705 Mount Auburn Street, Watertown, MA 02472, Attn:
More informationMedication Therapy Management: Improving Health and Saving Money
Medication Therapy Management: Improving Health and Saving Money Ed Staffa, RPh Vice President, Pharmacy Mirixa Corporation estaffa@mirixa.com July 23, 2008 MTM At A Glance The U.S. health care system
More informationAs a self-insured employer, one of your biggest challenges and potentially one of the
Opioids and Your Injured Worker An expert explains the real impact of opioid therapy on your workers compensation costs By Edward J. Bernacki, M.D., M.P.H. As a self-insured employer, one of your biggest
More informationManaged Care Trends in Statin Usage GARY R. BAZALO, MS, MBA
PHARMACY UTILIZATION Managed Care Trends in Statin Usage GARY R. BAZALO, MS, MBA ABSTRACT Purpose HMG-CoA reductase inhibitors ( statins ) have become the drug class of choice for the treatment of hyperlipidemia.
More informationAntidepressant Medication Therapy in Primary Care July 25, 2013
New York State Collaborative Care Initiative Antidepressant Medication Therapy in Primary Care July 25, 2013 http://uwaims.org Presenter Building on 25 years of Research and Practice in Integrated Mental
More informationSSRIs In Society: What Are Their Long-term Effects?
SSRIs In Society: What Are Their Long-term Effects? Robert Whitaker April 2013 U.S. Disability in the Prozac Era Millions of adults, 18 to 66 years old 5 4 3 2 1 0 1987 1989 1991 1993 1995 1997 1999 2001
More informationWalgreens (WAG) Analyst: Juan Fabres Fall 2014
Recommendation: Buy Target Price August 31, 2016: $77.57 1. Reasons for the Recommendation With the acquisition of Alliance Boots in Europe, Walgreens will be the first US pharmacy to operate retail stores
More informationPSYCHOTROPIC MEDICATION UTILIZATION PARAMETERS FOR CHILDREN AND YOUTH IN FOSTER CARE
PSYCHOTROPIC MEDICATION UTILIZATION PARAMETERS FOR CHILDREN AND YOUTH IN FOSTER CARE Introduction and General Principles April 2017 Adapted for New Mexico from with permission from the Texas Department
More informationUnderstanding the Challenges of Managing Mental Health in the Workplace With a Focus on ADHD
Understanding the Challenges of Managing Mental Health in the Workplace With a Focus on ADHD Dr. Martin Katzman, BSc, MD, FRCPC Clinic Director: Staff Psychiatrist: Centre for Addiction and Mental Health
More informationMaking decisions about therapy
JANUARY 2011 Making decisions about therapy Making decisions about treating your HIV may feel overwhelming. Developing a plan that helps you think about, plan for and make treatment decisions can help.
More informationPrescription Medication Guidelines for Medical Providers in CorVel s CorCare and Care IQ Networks
Prescription Medication Guidelines for Medical Providers in CorVel s CorCare and Care IQ Networks Patient Health and Safety Guidelines Prescription Medications Policy Update / April 2017 In connection
More informationOpioids drive continued increase in drug overdose deaths
CDC: Drug overdose deaths increase for 11th consecutive year Opioids drive continued increase in drug overdose deaths Atlanta, GA, USA (February 20, 2013) - Drug overdose deaths increased for the 11th
More informationHedis Behavioral Health Measures
Hedis Behavioral Health Measures Generating better health outcomes and improving HEDIS scores is a positive outcome for everyone. Magellan Complete Care is offering support by providing the details of
More informationEconomic Study Estimates Meth Abuse Costs the U.S. $23.4 Billion
Economic Study Estimates Meth Abuse Costs the U.S. $23.4 Billion Washington, D.C. February 4, 2009 A RAND Corporation study released today, The Economic Cost of Methamphetamine Use in the United States,
More informationMethadone Maintenance 101
Methadone Maintenance 101 OTP/DAILY DOSING CLINICS - ANDREW PUTNEY MD Conflicts of Interest - Employed by Acadia HealthCare 1 Why Methadone? At adequate doses methadone decreases opioid withdrawal symptoms
More informationManaging Depression as a Chronic Condition. D. Green MD TOH/Bruyere Shared Care Program
Managing Depression as a Chronic Condition D. Green MD TOH/Bruyere Shared Care Program None Financial disclosure Objectives To review key concepts relevant to understanding the course of depression To
More informationCondensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia
Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia I. Key Points a. Schizophrenia is a chronic illness affecting all aspects of person s life i. Treatment Planning Goals 1.
More informationMail Order Is Not For Everyone!
Mail Order Is Not For Everyone! Face to face patient counseling by pharmacists can have a powerful impact on long term health care costs and quality. So, the way health plan sponsors promote mail and generics
More informationUnited Kingdom Editors:
Editors: LEO Innovation Lab and The Happiness Research Institute Copenhagen,, October 2018 LEO Innovation Lab in cooperation with The Happiness Research Institute, 2018. All rights reserved. Any part of
More informationMolina Healthcare of Texas
Texas Standard Prior Authorization Form Addendum Molina Healthcare of Texas Ingrezza (Marketplace) This fax machine is located in a secure location as required by HIPAA Regulations. Complete / Review information,
More informationREFERENCE CODE GDHC224CFR PUBLICAT ION DATE FEBRUARY 2014 SCHIZOPHRENIA US DRUG FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC224CFR PUBLICAT ION DATE FEBRUARY 2014 SCHIZOPHRENIA Executive Summary Schizophrenia Sales in the US, 2012 The combined sales of medications carrying an indication in schizophrenia in
More informationExpert Perspectives. December 13, 2008 New York City. Acute and Maintenance. Treatment of Bipolar Disorder:
Acute and Maintenance Treatment of Bipolar Disorder: Expert Perspectives December 13, 2008 New York City Sponsored by the NYU Post-Graduate Medical School The Post-Graduate Medical School of the New York
More informationMaryland Department of Health and Mental Hygiene /Office of Systems, Operations and Pharmacy. Date Prescription will Start Denying at the
Maryland Medicaid Pharmacy Program & News ViewsNovember 2013 Maryland Department of Health and Mental Hygiene /Office of Systems, Operations and Pharmacy The Antipsychotic Peer Review Program is Expanding!
More information2) Percentage of adult patients (aged 18 years or older) with a diagnosis of major depression or dysthymia and an
Quality ID #370 (NQF 0710): Depression Remission at Twelve Months National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Prevention, Treatment, and Management of Mental Health
More informationREFERENCE CODE GDHC423DFR PUBLICAT ION DATE M AY 2014 ABILIFY (MAJOR DEPRESSIVE DISORDER) - FORECAST AND MARKET ANALYSIS TO 2023
REFERENCE CODE GDHC423DFR PUBLICAT ION DATE M AY 2014 ABILIFY (MAJOR DEPRESSIVE DISORDER) - Executive Summary Table below presents the key metrics for Abilify in the seven major pharmaceutical markets
More informationSafe, effective, affordable drug choices: online tool for payers and patients.
Executive summary: Rising healthcare costs and greater access to medical information drive patients to seek options for their drug therapy. The MedAlternatives database by Gold Standard/Elsevier empowers
More informationJefferies Healthcare Conference. June 2016
Jefferies Healthcare Conference June 2016 Today s Speakers John Figueroa Chief Executive Officer Vic Breed Chief Financial Officer Joined Genoa in July 2014 Previously served the dual roles of CEO of Apria
More informationMood Disorders for Care Coordinators
Mood Disorders for Care Coordinators David A Harrison, MD, PhD Assistant Professor, Dept of Psychiatry & Behavioral Sciences University of Washington School of Medicine Introduction 1 of 3 Mood disorders
More informationIntegration How Can Behavioral Health And Health Care Be Better Coordinated?
Integration How Can Behavioral Health And Health Care Be Better Coordinated? Mental Health America Annual Conference June 8, 2013 Harvey Rosenthal, NYAPRS New York Association of Psychiatric Rehabilitation
More informationCONFRONTING THE OPIOID EPIDEMIC. e-book: Introducing OptumRx Opioid Risk Management
CONFRONTING THE OPIOID EPIDEMIC 2 0 1 8 OPIOID ABUSE IS A CRISIS IN THE U.S. OptumRx Opioid Risk Management attacks this complex, deeply embedded problem with a comprehensive approach featuring five interrelated
More informationMajor Depressive Disorder Websites Reviewed by Felisha Lotspeich
Major Depressive Disorder Websites Reviewed by Felisha Lotspeich Major depression. (2010). https://health.google.com/health/ref/major+depression This Website gives basic information about major depressive
More information7-year Journey reaps Decline in Medical Spend. Who is Goodwill?
7-year Journey reaps Decline in Medical Spend Who is Goodwill? 1 Developing the Story Emotional Financial Educational Change in Access to Care Acute Care System Planned Care System Use medical savings
More informationPATIENT AUTHORIZATION AND NOTICE OF RELEASE OF INFORMATION (PAN)
XOLAIR Access Solutions is a free program for you from Genentech. We work to help you pay for your XOLAIR (omalizumab) for subcutaneous use. We can help in many different ways. We assist people who have
More informationHome-Based Asthma Interventions: Keys to Success
Home-Based Asthma Interventions: Keys to Success Setting the Stage Asthma affects 25 million Americans (one in every 12 people), including six million children. The costs of uncontrolled asthma -- including
More informationPITTSBURGH MERCY: COMPREHENSIVE INTEGRATED CARE JUNE 6, 2018
PITTSBURGH MERCY: COMPREHENSIVE INTEGRATED CARE JUNE 6, 2018 AN ENHANCED MEDICAL HOME MODEL FOR THE SMI POPULATION Comprehensive Care Patient Centered Care Coordinated Care Accessible Services Quality
More informationOctober 15, Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852
Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 Re: Docket No. FDA-2012-N-0548 To Whom It May Concern: The American Dental Association
More informationLike others here today, we are very conflicted on the FDA s proposal on behind-thecounter medications, but thank you for raising the issue.
Statement of Consumers Union William Vaughan, Senior Policy Analyst before the US Food and Drug Administration Public Meeting on Behind the Counter Availability of Drugs November 14, 2007 Consumers Union
More informationLATUDA Commercial Update
LATUDA Commercial Update LATUDA Meeting (Tokyo) January 2011 Mark Iwicki President and Chief Operating Officer Sunovion Pharmaceuticals Inc. Sunovion Is Uniquely Positioned to Deliver Strong Performance
More informationIOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road (515)
IOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road (515) 974-3131 -866-626-0216 Brett Faine, Pharm.D. Larry Ambroson, R.Ph. Casey Clor, M.D. Professional Staff: Mark Graber, M.D., FACEP
More informationREFERENCE CODE GDHC420DFR PUBLICAT ION DATE M AY 2014 FETZIMA (MAJOR DEPRESSIVE DISORDER) - FORECAST AND MARKET ANALYSIS TO 2023
REFERENCE CODE GDHC420DFR PUBLICAT ION DATE M AY 2014 FETZIMA (MAJOR DEPRESSIVE DISORDER) - Executive Summary Table below presents the key metrics for Fetzima in the seven major pharmaceutical markets
More informationAre Specialty Pharmacy Drugs Worth the Cost? How Companies Can Make Them More Affordable.
Are Specialty Pharmacy Drugs Worth the Cost? How Companies Can Make Them More Affordable. BACKGROUND Your Host: Eric Bricker, MD Co-Founder & Chief Medical Officer - Compass Professional Health Services
More informationKaiser Telecare Program for Intensive Community Support Intensive Case Management Exclusively for Members within a Managed Care System
Kaiser Telecare Program for Intensive Community Support Intensive Case Management Exclusively for Members within a Managed Care System 12-Month Customer Report, January to December, 2007 We exist to help
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Rexulti) Reference Number: CP.PMN.68 Effective Date: 11.05.15 Last Review Date: 02.18 Line of Business: Commercial, Health Insurance Marketplace, Medicaid Revision Log See Important Reminder
More informationREFERENCE CODE GDHC361DFR PUBLICAT ION DATE FEBRUARY 2014 INVEGA (SCHIZOPHRENIA) FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC361DFR PUBLICAT ION DATE FEBRUARY 2014 INVEGA (SCHIZOPHRENIA) Executive Summary Invega : Key Metrics in the Seven Major Pharmaceutical Markets, 2012 2022 2012 Market Sales US 5EU Japan
More informationREFERENCE CODE GDHC426DFR PUBLICAT ION DATE M AY 2014 CARIPRAZINE (MAJOR DEPRESSIVE DISORDER) - FORECAST AND MARKET ANALYSIS TO 2023
REFERENCE CODE GDHC426DFR PUBLICAT ION DATE M AY 2014 CARIPRAZINE (MAJOR DEPRESSIVE DISORDER) - Executive Summary Table below presents the key metrics for cariprazine in the Major Depressive Disorder (MDD)
More informationLouisiana. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Louisiana Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationAyrshire Employability Project
Integration Joint Board 18 th January 2018 Agenda Item 8 Subject: Transforming Care After Treatment (TCAT) Ayrshire Employability Project Purpose: Recommendation: To update the Integration Joint Board
More informationJuly 7, Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm Rockville, MD 20852
July 7, 2012 Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: Docket No. FDA 2012-N-0408: Risk Evaluation and Mitigation Strategy Assessments:
More informationChildren On Psychotropic Medications
Children On Psychotropic Medications Considerations for Systematic Care of Children Using Rational Psychopharmacology as Part of an Overall Treatment Strategy Presented to Gabriel Myers Workgroup by Dr.
More informationFlorida State University Libraries
Florida State University Libraries Faculty Publications College of Social Work 2014 Overdiagnosis Jeffrey R. Lacasse and Jonathan Leo Follow this and additional works at the FSU Digital Library. For more
More informationDRUG DEVELOPMENT. How do drugs become available for prescription?
DRUG DEVELOPMENT How do drugs become available for prescription? OUTLINE Birth Idea, Chemistry, Pharmacology. Obtaining a patent. Passing regulatory hurdles (IND and NOC) Pre-clinical trials and data.
More information